To investigate this, we compared the differentially expressed genes from SRSF2-mutated AML cases (SRSF2mt) in the BEAT-AML database with our RNA-sequencing analysis of FBXO11 KO MDS-L cells (Supplemental Tables S4 and S5). The gene discussed is FBXO11; the disease is myelodysplastic syndrome.